Cargando…

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study

BACKGROUND: Hepatitis B virus (HBV) reactivation with a hepatitis flare is a common complication in lymphoma patients treated with immunotherapy and/or chemotherapy. Anti-HBV prophylaxis is suggested for non-Hodgkin lymphoma (NHL) patients undergoing rituximab therapy, even those with resolved HBV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Yu-Fen, Yang, Ching-I, Du, Jeng-Shiun, Lin, Ming-Hui, Tang, Shih-Hao, Wang, Hui-Ching, Cho, Shih-Feng, Liu, Yi-Chang, Su, Yu-Chieh, Dai, Chia-Yen, Hsiao, Hui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2019
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741285/ https://www.ncbi.nlm.nih.gov/pubmed/31565551 http://dx.doi.org/10.7717/peerj.7481

Ejemplares similares

Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab
por: Haider, Mahnur, et al.
Publicado: (2020)

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation
por: Zhang, Dali, et al.
Publicado: (2022)

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan
por: Tsai, Pei-Chien, et al.
Publicado: (2021)

Chronic Hepatitis B stigma in Ghana: a qualitative study with patients and providers
por: Adjei, Charles Ampong, et al.
Publicado: (2019)

Beyond the diagnosis: a qualitative exploration of the experiences of persons with hepatitis B in the Accra Metropolis, Ghana
por: Adjei, Charles Ampong, et al.
Publicado: (2017)

The role of hepatic microenvironment in hepatic fibrosis development
por: Meng, Ying, et al.
Publicado: (2022)

Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013)

Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case–control study
por: Fu, Kuo-Yu, et al.
Publicado: (2022)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol
por: Ti, Lianping, et al.
Publicado: (2018)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison
por: Byrne, Christopher J, et al.
Publicado: (2023)

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis
por: Xu, Xiaoyong, et al.
Publicado: (2018)

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center
por: Alkhalifah, Ridha H, et al.
Publicado: (2023)

Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial
por: Xu, Wenxiong, et al.
Publicado: (2021)

Clinical and Virological Features of Acute Hepatic Exacerbations in Patients With Chronic Hepatitis B Virus Infection
por: Bestas, Remzi, et al.
Publicado: (2021)

The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia
por: Bogdanović, Zoran, et al.
Publicado: (2016)

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015)

Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
por: Cheng, Wenli, et al.
Publicado: (2023)

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
por: Péneau, Camille, et al.
Publicado: (2022)

Hepatic autotaxin overexpression in infants with biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Assessment of a primary care e-support package of automated case finding, simplified treatment algorithm and decision support to increase hepatitis B treatment uptake in primary care clinics in Australia (SIMPLY-B Study): protocol for a pilot evaluation
por: Moussa, Dina, et al.
Publicado: (2023)

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
por: Havens, Jennifer R, et al.
Publicado: (2021)

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
por: Burm, Rani, et al.
Publicado: (2023)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
por: Fan, Rong, et al.
Publicado: (2016)

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial
por: Jopson, Laura, et al.
Publicado: (2015)

A Case of Hepatitis B Virus Reactivation Triggered by Acute Epstein-Barr Virus Infection
por: Beran, Azizullah, et al.
Publicado: (2021)

The association between serum folate and ultrasound - defined hepatic steatosis
por: Chen, Xingxing, et al.
Publicado: (2023)

Risk factors for post-endoscopic retrograde cholangiopancreatography cholangitis in patients with hepatic alveolar echinococcosis—an observational study
por: Du, Fei, et al.
Publicado: (2022)

Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study
por: Chang, Te-Sheng, et al.
Publicado: (2021)

Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus
por: Chemin, Isabelle, et al.
Publicado: (2021)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
por: Shih, Yi-Fen, et al.
Publicado: (2020)

Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
por: Zaimi, Yosra, et al.
Publicado: (2021)

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
por: Tsai, Yu-Chi, et al.
Publicado: (2023)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
por: Medina Pizaño, Mariana Yazmin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7us6a7e57ts59r5e9pdf3h2fo0